Discontinued drugs in 2008: cardiovascular drugs
Z Xu-song, X Bing-ren - Expert opinion on investigational drugs, 2009 - Taylor & Francis
Z Xu-song, X Bing-ren
Expert opinion on investigational drugs, 2009•Taylor & FrancisThis perspective is part of an annual series of papers discussing drugs dropped from clinical
development in the previous year. Specifically, this paper focuses on the 16 cardiovascular
drugs discontinued in 2008. Information for this perspective was derived from a search of the
Pharmaprojects database for drugs discontinued after reaching Phase I–III clinical trials.
development in the previous year. Specifically, this paper focuses on the 16 cardiovascular
drugs discontinued in 2008. Information for this perspective was derived from a search of the
Pharmaprojects database for drugs discontinued after reaching Phase I–III clinical trials.
This perspective is part of an annual series of papers discussing drugs dropped from clinical development in the previous year. Specifically, this paper focuses on the 16 cardiovascular drugs discontinued in 2008. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I – III clinical trials.
Taylor & Francis Online